DEF 14AThe Ballot
Viking Therapeutics, Inc. files DEF 14A
Filed Apr 7, 2017 · 9y ago · Accession 0001564590-17-006213
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Viking Therapeutics, Inc.
- Ticker
- VKTX
- CIK
- 1607678
- Form type
- DEF 14A
- Filing date
- Apr 7, 2017
- Report date
- May 23, 2017
- Document
- vktx-def14a_20170523.htm
- Size
- 953 KB